9.34澳幣0.07(0.8%)
2023/11/30更新
績效 / 1月0.22%
3月4.06%
1年3.65%
晨星評等-
- 1.現金10.97%
- 2.股票38.07%
- 3.債券0.00%
- 4.其他50.96%
- 1.美國48.52%
- 2.歐洲不包含歐元區17.69%
- 3.英國13.81%
- 4.歐元區4.68%
- 5.日本1.90%
- 1.健康護理74.92%
- 2.周期性消費3.68%
- 3.工業2.66%
- 4.防守性消費1.87%
- 5.金融服務1.85%
- 6.基本物料1.61%
- 1.Novo Nordisk A/S Class B9.14%
- 2.Eli Lilly and Co9.05%
- 3.Alcon Inc5.71%
- 4.AstraZeneca PLC5.71%
- 5.UnitedHealth Group Inc5.05%
- 6.GSK PLC4.12%
- 7.Becton Dickinson & Co4.08%
- 8.Thermo Fisher Scientific Inc4.00%
- 9.AbbVie Inc3.53%
- 10.Grifols SA Participating Preferred2.75%
- 1.現金10.97%
- 2.股票38.07%
- 3.債券0.00%
- 4.其他50.96%
- 1.健康護理74.92%
- 2.周期性消費3.68%
- 3.工業2.66%
- 4.防守性消費1.87%
- 5.金融服務1.85%
- 6.基本物料1.61%
- 1.美國48.52%
- 2.歐洲不包含歐元區17.69%
- 3.英國13.81%
- 4.歐元區4.68%
- 5.日本1.90%
- 1.Novo Nordisk A/S Class B9.14%
- 2.Eli Lilly and Co9.05%
- 3.Alcon Inc5.71%
- 4.AstraZeneca PLC5.71%
- 5.UnitedHealth Group Inc5.05%
- 6.GSK PLC4.12%
- 7.Becton Dickinson & Co4.08%
- 8.Thermo Fisher Scientific Inc4.00%
- 9.AbbVie Inc3.53%
- 10.Grifols SA Participating Preferred2.75%